Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
-
Publication Venue For
-
Gut Colonization Preceding Mucosal Barrier Injury Bloodstream Infection in Pediatric Hematopoietic Stem Cell Transplantation Recipients..
25:2274-2280.
2019
-
Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia..
24:726-733.
2018
-
Payment and Care for Hematopoietic Cell Transplantation Patients: Toward a Specialized Medical Home for Complex Care Patients..
24:4-12.
2018
-
Decreased Gram Negative Bloodstream and C. Difficile Infections with Early Ciprofloxacin/Metronidazole Prophylaxis in Myeloablative Allogeneic Hematopoietic Stem Cell Transplant.
23:S390-S390.
2017
-
Prediction of Poor Mobilization of Autologous CD34+ Cells with Growth Factor in Multiple Myeloma Patients: Implications for Risk-Stratification.
20:222-228.
2014
-
A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.
20:326-336.
2014
-
Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.
20:402-408.
2014
-
Karl Georg Blume, MD.
19:845-846.
2013
-
Development of A Segment-Based Aldehyde Dehydrogenase Assay to Determine Umbilical Cord Blood Unit (CBU) Potency.
15:44-44.
2009
-
Easing the TBI Experience in the Pre-School Patient.
15:32-33.
2009
-
Isolation and Expansion of Oligodendrocytes from Thawed, Cryopreserved Human Umblilical Cord Blood.
15:86-86.
2009
-
Negative Impact of Post-Thaw Washing on the Overall Survival (OS) and Disease Free Survival (DFS) of Patients Receiving Plasma Depleted (PD) Cord Blood (CB) Transplantation.
15:17-17.
2009
-
Plasmacytoid CD123+ Dendritic Cell Recovery And Reduced Activation State Of Circulating CD8+ T Cells Predict Survival After Unrelated Cord Blood Transplant (UCBT).
15:136-136.
2009
-
Survival Following Allogeneic Stem Cell Transplantation for Congenital Immunodeficiency and Metabolic Disorders.
15:78-78.
2009
-
Unrelated Umbilical Cord Blood Transplantation is an Effective Therapy for Wiskott-Aldrich Syndrome.
15:76-76.
2009
-
Allogeneic memory T cell response.
14:20-22.
2008
-
Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics..
13:1422-1426.
2007
-
Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors..
13:1249-1267.
2007
-
Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival..
13:1073-1082.
2007
-
Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy..
13:665-674.
2007
-
Radiation Emergencies: Evaluation, Management, and Transplantation.
13:103-106.
2007
-
Regulatory T Cells: Historical Perspective.
13:11.
2007
-
Antigen-specific T-lymphocyte function after cord blood transplantation..
12:1335-1342.
2006
-
Diffuse alveolar hemorrhage: retrospective review of clinical outcome in allogeneic transplant recipients treated with aminocaproic acid..
12:949-953.
2006
-
Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation..
12:919-927.
2006
-
Transplantation and aging..
12:893-898.
2006
-
Acute hemolysis in a patient with cytomegalovirus pneumonitis treated with intravenous immunoglobulin (IVIG)..
12:786-788.
2006
-
Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study..
12:778-785.
2006
-
Acute radiation injury: contingency planning for triage, supportive care, and transplantation..
12:672-682.
2006
-
Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering..
12:608-622.
2006
-
Vascular endothelial cells produce soluble factors that mediate the recovery of human hematopoietic stem cells after radiation injury..
12:530-540.
2006
-
Longitudinal analysis of T-cell receptor variable beta chain repertoire in patients with acute graft-versus-host disease after allogeneic stem cell transplantation..
12:335-345.
2006
-
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report..
12:252-266.
2006
-
Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone..
12:195-203.
2006
-
Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases..
12:184-194.
2006
-
Gene expression profiling and outcome prediction in non-Hodgkin lymphoma..
12:50-52.
2006
-
Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis..
12:22-30.
2006
-
Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005..
11:862-870.
2005
-
Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience..
11:637-646.
2005
-
gammadelta T cells: a new frontier for immunotherapy?.
11:161-168.
2005
-
Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT)..
11:149-160.
2005
-
Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma..
11:39-46.
2005
-
Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease..
11:47-55.
2005
-
Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens..
10:569-575.
2004
-
Minors come of age: Minor histocompatibility antigens and graft-versus-host disease..
10:215-223.
2004
-
Racial diversity with high nucleated cell counts and CD34 counts achieved in a national network of cord blood banks..
10:269-275.
2004
-
Umbilical cord blood transplantation in adults using myeloablative and nonmyeloablative preparative regimens..
10:1-22.
2004
-
Unrelated umbilical cord blood transplantation in adult patients..
9:772-780.
2003
-
Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome..
9:698-705.
2003
-
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases..
9:583-591.
2003
-
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia..
9:519-528.
2003
-
Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells..
9:312-319.
2003
-
4-hydroperoxycyclophosphamide--purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia..
9:183-188.
2003
-
High-dose chemotherapy and hematopoietic support for patients with high-risk primary breast cancer and involvement of 4 to 9 lymph nodes..
8:666-673.
2002
-
Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias..
8:47-56.
2002
-
Nonmyeloablative regimen preserves "niches" allowing for peripheral expansion of donor T-cells..
8:249-256.
2002
-
Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study..
7:257-264.
2001
-
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease..
7:552-560.
2001
-
Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation..
7:274-278.
2001
-
Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients..
7:395-399.
2001
-
Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation..
7:343-351.
2001
-
Secondary failure of platelet recovery after hematopoietic stem cell transplantation..
7:154-162.
2001
-
Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia..
7:665-673.
2001
-
T-Cell recovery in adults and children following umbilical cord blood transplantation..
7:454-466.
2001
-
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease..
6:613-620.
2000
-
Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients..
6:576-591.
2000
-
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial..
6:254-261.
2000
-
Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells..
6:506-512.
2000
-
Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: no improvement in outcomes compared with single-course high-dose therapy..
6:58-69.
2000
-
Graft-versus-host disease prevention by rapamycin: cellular mechanisms..
6:529-536.
2000
-
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma..
6:352-358.
2000
-
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival..
5:285-291.
1999
-
HLA-C disparity between patients and unrelated donors matched for HLA-A, -B, and -DRB1 alleles: impact of serological vs. DNA typing for HLA-A and -B loci..
5:77-85.
1999
-
Pathophysiologic mechanisms of acute graft-vs.-host disease..
5:347-356.
1999
-
Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts..
5:369-378.
1999
-
Retroviral vector-mediated gene transfer into umbilical cord blood-derived megakaryocyte and platelet progenitors..
5:215-221.
1999
-
A randomized trial of recombinant human interleukin-11 following autologous bone marrow transplantation with peripheral blood progenitor cell support in patients with breast cancer..
4:134-141.
1998
-
Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation..
4:20-26.
1998
-
Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions..
3:310-315.
1997
-
Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies..
3:324-330.
1997
-
Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation..
3:331-340.
1997
-
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?.
3:194-201.
1997
-
Graft-versus-host disease: the viewpoint from the donor T cell..
3:1-10.
1997
-
Barriers to bone marrow transplantation for sickle cell anemia..
2:100-104.
1996
-
Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma..
2:76-85.
1996
-
Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors..
2:93-99.
1996
-
Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease..
2:86-92.
1996
-
A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery..
2:44-53.
1996
-
Preemptive ganciclovir administration based solely on asymptomatic pulmonary cytomegalovirus infection in allogeneic bone marrow transplant recipients: long-term follow-up..
1:88-93.
1995
-
Financial Incentives to Increase Stool Collection Rates for Microbiome Studies in Adult Bone Marrow Transplant Patients
2020
-
Phase II Trial of Pasireotide to Prevent GI Toxicity and Acute Gvhd in Allogeneic HSCT
2020
-
The Effect of Limited-English Proficiency on Hematopoietic Stem Cell Transplantation Outcomes: A Retrospective Cohort Study of Hispanic Pediatric Transplant Patients at a Single Institution.
2020
-
Transplant Physicians' Attitudes on Candidacy for Allogeneic Hematopoietic Cell Transplantation (HCT) in Older Patients: The Need for a Standardized Geriatric Assessment (GA) Tool
2020
-
Transplant- and Disease-Related Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Patients with Cerebral Adrenoleukodystrophy Vary By Donor Cell Source, Conditioning Regimen, and Stage of Cerebral Disease
2020
-
Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC)
2020
-
Feasibility of Centralized Electronic Patient-Reported Outcome (ePRO) Collection By an Outcome Registry, a CIBMTR Study of Patients on the Centers for Medicaid & Medicare Coverage with Evidence Development (CMS CED) Myelodysplasia Protocol
2020
-
Demonstrating Efficacy of CHG Bathing Treatment for Inpatient Adult Hematopoietic Stem Cell Transplant Recipients Improves Daily Compliance Among Staff
2019
-
Duoc-01, a Cord Blood Derived Cell Therapy Product, Ameliorates Experimental Autoimmune Encephalomyelitis
2019
-
Effects of Vitamin D Levels on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Children
2019
-
Evaluating the Utilization of Line Snugglers in Protecting and Organizing Central Lines in a Pediatric Blood and Marrow Transplant Population
2019
-
Microbiota Injury in Auto-HCT Is Frequent, Occurs across Geography, and Is Comparable to That Observed in Allo-HCT
2019
-
Multicenter Microbiota Analysis Indicates That Pre-HCT Microbiota Injury Is Prevalent across Geography and Predicts Poor Overall Survival
2019
-
Nutrition Practices in Hematopoietic Stem Cell Transplantation (HSCT): A Comparison between Guidelines and Clinical Practice
2019
-
Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Patients with Cerebral Adrenoleukodystrophy (CALD): Results from an Ongoing, Large, Multicenter, Observational Study
2019
-
Outcomes of Umbilical Cord Blood Transplantation in Children with Batten Disease
2019
-
Phase I, Dose Escalation Study of Naive T-Cell Depleted Donor Lymphocyte Infusion Following Allogeneic Stem Cell Transplantation
2019
-
Rapid and Robust CD4+and CD8+T-, NK-, B-Cell, Dendritic Cell, and Monocyte Reconstitution after Nicotinamide-Expanded Cord Blood Transplantation
2019
-
Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Updated Analysis of the ELIANA Clinical Trial
2019
-
Use of Unlicensed Unrelated Umbilical Cord Blood Expands Access to Underserved Patients: Report of 2466 Transplants in a Racially/Ethnically Diverse Population
2019
-
A National Survey Study of Transplant Physicians' Attitudes About Palliative Care
2018
-
A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord (R) [Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide] and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD
2018
-
A Phase 3 Single-Arm, Prospective Study of Remestemcel-L, Ex-Vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Steroid Refractory Acute Gvhd in Pediatric Patients
2018
-
Analysis of the CD34+Cell Content of 126, 341 Cord Blood (CB) Units in the NMDP be the Match Inventory: Implications for CB Transplantation and Public Banking
2018
-
Intestinal Microbiota Injury during Allo-Hct is Generalizable across Transplantation Centers and is Associated with Increased Mortality, Broad-Spectrum Antibiotics, and Decreased Calorie Intake
2018
-
Nicord Single Unit Expanded Umbilical Cord Blood Transplantation (UCBT): Final Results of a Multicenter Phase I/ II Trial
2018
-
The Influence of Stem Cell Source on Chronic-GvHD Free, Leukemia Free Transplant Survival in Pediatric Patients with Acute Myeloid Leukemia
2018
-
Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit Lymphoma
2017
-
Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke (CoBIS): Clinical Outcomes From a Phase 1 Study
2017
-
Augmentation of Allogenic Cord Blood (CB) Transplantation for Inherited Metabolic Diseases with CB-Derived Intrathecal Cellular Therapy, Duoc-01
2017
-
Decreased Gram Negative Bloodstream and C. Difficile Infections with Early Ciprofloxacin/Metronidazole Prophylaxis in Myeloablative Allogeneic Hematopoietic Stem Cell Transplant
2017
-
Excellent Outcomes in 1589 Patients Receiving Umbilical Cord Blood Transplantation Using Unlicensed Units From a Centralized Cord Blood Registry
2017
-
Genotype, Phenotype and T Cell Counts at One Year Predict Survival and Long Term Immune Reconstitution after Transplantation in Severe Combined Immune Deficiency (SCID)-The Primary Immune Deficiency Treatment Consortium (PIDTC)
2017
-
Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit Lymphoma
2017
-
Outcomes of Second Transplants for Patients with Hematological Malignancies Who Relapse after First Transplant: A Retrospective Analysis of a Single Institution Experience
2017
-
Randomized Trial of Inpatient Palliative Care Intervention for Patients Hospitalized for Hematopoietic Stem Cell Transplantation (HCT)
2017
-
Successful Engraftment of Umbilical Cord Blood (UCB) Cells after Co-Transplantation of Nicord (R) (Ex Vivo Expanded UCB Progenitor Cells with Nicotinamide) and an Unmanipulated UCB Unit after Myeloablative Chemotherapy in Severe Sickle Cell Disease
2017
-
Treatment of Adenovirus (AdV) Infection in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients (pts) with Brincidofovir: Final 36 Week Results from the Advise Trial
2017
-
Treatment of Childhood Apraxia with Autologous Cord Blood Infusions
2017
-
Trends in Survival Outcomes Among Patients (pts) Relapsing Early after Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma (MM) (CIBMTR Study # MM14-03)
2017
-
Adequately Dosed Autologous Cord Blood Infusion Is Associated with Motor Improvement in Children with Cerebral Palsy
2016
-
Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke
2016
-
Clinical and Immunomodulatiory Outcomes of Microtransplantation for AML
2016
-
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial
2016
-
Early Allogeneic Stem Cell Transplantation Appears to Improve Outcomes in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/T-LBL) Patients: A Multi-Institutional Review
2016
-
Effect of Human Mesenchymal Stem Cells (Remestemcel-L) on Clinical Response and Survival Confirmed in a Large Cohort of Pediatric Patients with Severe High-Risk Steroid-Refractory Acute Graft Versus Host Disease
2016
-
Efficacy of Autologous Stem Cell Transplantation in Older Multiple Myeloma Patients
2016
-
Ex-Vivo Expansion of Previously Cryopreserved, Thawed and Re-Cryopreserved Cord Blood Mononuclear Cells (CBMC) Utilizing K562-mbIL21-41BBL; Potential for Adoptive Cellular Immunotherapy Post Umbilical Cord Blood Transplantation (UCBT)
2016
-
Growth Factor Receptor-Bound Protein 10 (Grb10) Regulates Hematopoietic Stem Cell (HSC) Self-Renewal and Regeneration Via Control of mTOR Signaling
2016
-
Interim Analysis of an Observational Study Assessing T Cell Receptor Diversity As an Early Predictor of NRM in Cord Blood Transplant Recipients
2016
-
Long-Term Functional Outcomes following Hematopoietic Stem Cell Transplantation for Krabbe Disease
2016
-
Optimization of the Aldehyde Dehydrogenase-Based Cord Blood Potency Assay Using Red Blood Cell Depletion
2016
-
Outcomes after Allogeneic Transplant for Lymphoplasmacytic Lymphoma/ Waldenstrom Macroglobulinemia (LPL/WM): A Center for International Blood and Marrow Transplant Research Analysis
2016
-
Pooled Dose Response Analysis of Defibrotide in >1600 Patients for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome
2016
-
Poor T Cell Reconstitution at 100 Days after T Cell-Replete Hematopoietic Cell Transplantation (HCT) for SCID Is Associated with Later Risk of Death or Need for 2nd Transplant in the 6901 Prospective Study of the Pidtc
2016
-
Pulse Cyclophosphamide for Steroid-Refractory Chronic Graft-Versus-Host Disease
2016
-
SGN-CD33A (Vadastuximab Talirine) followed by Allogeneic Hematopoietic Stem Cell Transplant (AlloHSCT) Results in Durable Complete Remissions (CRs) in Patients with Acute Myeloid Leukemia (AML)
2016
-
Targeting Cord Blood Units with Higher Total Nucleated Cell Count for Inclusion in a Public Cord Blood Bank: Impact on Inventory Diversity and Self-Sustainability
2016
-
Umbilical Cord Blood Transplantation for Cartilage Hair Hypoplasia: A Single Center Experience Demonstrates Excellent Outcomes Using Myeloablative Preparative Regimens
2016
-
Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis
2016
-
Use of Umbilical Cord Blood to Treat Non-Fatal Submersion Events
2016
-
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
2015
-
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival
2015
-
Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease
2015
-
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
2015
-
Engraftment Failure or Aplastic Anemia: A Case Report
2015
-
Fibrinogen-Coated Nanospheres Prevent Thrombocytopenia-Related Bleeding
2015
-
Hyperthyroidism As a Complication Following Myloablative Therapy and Stem Cell Transplantation for Childhood Diseases
2015
-
Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
2015
-
Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation
2015
-
Outcomes of Second Unrelated Donor Cord Blood Transplants (UCBT) Performed in Children with Graft Failure of Autologous Recovery Following the First UCBT
2015
-
Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection
2015
-
SGN-CD33A: Case Reports of Anti-Leukemic Activity and Bridge to Allogeneic Stem Cell Transplant (SCT) in Patients with Acute Myeloid Leukemia (AML)
2015
-
Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease
2015
-
Brincidofovir (CMX001) Is Well Tolerated in Highly Immunocompromised Pediatric Patients
2014
-
Experience in a Public Cord Blood Bank Using a Segment-Based Aldehyde Dehydrogenase Assay As a Biomarker for Umbilical Cord Blood Potency
2014
-
HLA-Mismatch Is Associated with Worse Outcomes after Myeloablative Conditioning and Unrelated Donor Hematopoietic Cell Transplantation: A Cibmtr Analysis
2014
-
Interplay of Recipient-Donor Matching for HLA, Race/Ethnicity and Gender on Long Term Outcomes in 365 Pediatric Recipients of Single 4/6 Matched Unrelated Cord Blood Transplantation (UCBT) after Myeloablative Therapy
2014
-
Late Effects in Infants and Young Children Following Umbilical Cord Blood Transplant Using Busulfan-Based, Myeloablative Non-TBI Conditioning Regimens
2014
-
Matched Pair Comparison of Busulfan/Cyclophosphamide/Etoposide (BuCyE) to Carmustine/Etoposide/Cytarabine/Melphalan (BEAM) Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation (autoHCT) for Lymphoma
2014
-
Predictors of Long-Term Clinical Outcome in Hurler Syndrome Patients after Successful Hematopoietic Cell Transplantation: An International Study
2014
-
Repeated Dosing of Autologous Cord Blood Is Safe and Feasible in Babies with Congenital Hydrocephalus
2014
-
Retrospective Study of 240 Patients with Severe Combined Immunodeficiency Transplanted from 2000-2009: A Report from the Primary Immune Deficiency Treatment Consortium of North America
2014
-
Twice-Weekly Brincidofovir (CMX001) Shows Promising Antiviral Activity in Immunocompromised Transplant Recipients with Asymptomatic Adenovirus Viremia
2014
-
Unrelated Umbilical Cord Blood Transplant for Diamond-Blackfan Anemia
2014
-
Feasibility of Cardiopulmonary Exercise Testing and Longitudinal Patient-Reported Outcome (PRO) Assessment in Patients Undergoing Hematopoietic Cell Transplantation
2013
-
Increased BLNK and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets
2013
-
Insulin-Like Growth Factor 1 Mitigates Hematopoietic Toxicity After Lethal Total Body Irradiation
2013
-
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
2013
-
Superior Survival After Single Unit Umbilical Cord Blood Transplantation (UCBT) in Children with Hematological Malignancies Treated on Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0501 Relative to the Cord Blood Transplantation (COBLT)
2013
-
Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation
2013
-
The Natural History of Children with Severe Combined Immunodeficiency Disease (SCID): The First Fifty Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
2013
-
Why Do Umbilical Cord Blood Units Fail to Qualify for Public Banking?
2013
-
Building a Legacy
2012
-
Cord Blood Transplantation for Long Term Management or Possible Cure of HIV Infection
2012
-
Dose Precision Using a Pretransplant Test PK of Intravenous Busulfan Prior to BuCyVP-16 Preparative Regimen in Lymphoma
2012
-
Egf Signaling Regulates Hematopoietic Regeneration Following Total Body Irradiation
2012
-
Incidence of Adrenal Insufficiency in Children with Sanfilippo Syndrome Type a Following UUCB Transplant – a Retrospective Study
2012
-
NiCord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
2012
-
Nursing Coordination of a Life-Saving Cadaveric Tandem Lung and Bone Marrow Transplant in a Pediatric Patient with Congenital Immunodeficiency and Pulmonary Failure
2012
-
Pleiotrophin Regulates Normal and Leukemic Hematopoietic Stem Cell Fate
2012
-
Qualification of Cord Blood Units for an Autologous Infusion Program for Pediatric Patients with Acquired Brain Injuries
2012
-
Relationships Among Commonly Used Measures of Cord Blood Potency, Aldhbr Cell Content, and Colony Forming Cell Content in Cord Blood Units Prior to Cryopreservation: Towards an Improved Metric for Potency of Banked Cord Blood
2012
-
Rhesus Macaque Natural CD4 Regulatory T Cells Exhibit Decreased Proliferation But Enhanced Suppression After Pulsing with Sirolimus
2012
-
Unrelated Cord Blood Transplantation (CBT) of 101 Hemoglobinopathy (HGB) Patients
2012
-
Use of Cyclosporine Is Associated with the Increase in Pre-Engraftment Syndrome After Myeloablative Dual Cord Blood Transplantation
2012
-
A Prospective Study of Reduced Intensity Conditioning (RIC) in Children Undergoing Unrelated Umbilical Cord Blood Transplantation (UCBT) for Non-Malignant Diseases: Preliminary Results Demonstrate a High Rate of Engraftment and Low Incidence of GVHD
2011
-
Caregivers Helping in Relieving Pain – C.H.I.R.P. Project
2011
-
Collection of G-CSF-Mobilized Granulocytes From Related Donors to Support Hematopoietic Stem Cell Transplant Recipients at High Risk of infection Is Safe and Feasible
2011
-
Cord Blood (CB) APGAR Score Is Predictive of Neutrophil Engraftment and Graft Failure Probabilities for Plasma Depleted/Reduced CB Products
2011
-
Cord Blood (CB) APGAR Score May Be Predictive of Transplant Related Mortality (TRM), Overall Survival (OS) and Disease-Free Survival (DFS) for Plasma Depleted/Reduced CB Products
2011
-
Differential Impact of HLA-A, -B, and -DRB1 Mismatching in Relation to Other Variables on the Outcomes of Myeloablative Unrelated Single Donor Umbilical Cord Blood Transplantation From 4/6 Matched Units in Children and Young Adults
2011
-
Durable Engraftment and Correction of Genetic Defect in Children with Congenital Amegakaryocytic Thrombocytopenia Following Myeloablative Umbilical Cord Blood Transplantation
2011
-
Educating Pediatric Outpatient Nurses to the Unique Challenges of Reduced Intensity Transplant Conditioning (RIC) Regimen in Children With Non-Malignant Disorders
2011
-
Experience With CMX001, a Novel Antiviral Drug, for Cytomegalovirus infections in Stem Cell Transplant Patients
2011
-
Fast Facts Flip Chart – A Quick Accessible Reference Guide for Busy Nurses
2011
-
Meeting the Challenge: Developing a Model to Care for an Adolescent Patient With Leukemia and Severe Autism
2011
-
Organ Function and Quality of Life Correlates at Randomization on the Scot (Scleroderma: Cyclophosphamide or Transplantation) Trial
2011
-
Outcomes of a 1-Day Nonmyeloablative Preparative Regimen for Primary Graft Failure After Allogeneic Stem Cell Transplantation
2011
-
Pleiotrophin Signaling Is Necessary for Hematopoietic Stem Cell Self Renewal and Is Regulated by the Bone Marrow Microenvironment
2011
-
Quality of Life Project – An Oral Presentation
2011
-
Through the Lens: Engaging School-Age Children and Adolescent SCT Patients in an Academic Photography Project
2011
-
Tie2+ Endothelial Cells Mediate Hematopoietic Stem Cell Regeneration Via EGF Signaling
2011
-
Time Sensitive Parameters of Immune Reconstitution Measured Between Day 100 and 1 Year Predict Survival After Unrelated Cord Blood Transplant (UCBT): The Dynamic Impact of Dendritic Cells, Tregs, and Thymic Recovery
2011
-
Vitamin D Deficiency in Children Undergoing Hematopoietic Stem Cell Transplantation
2011
-
A Prospective Study Of Donor Immuknow® As A Biomarker For Acute GvHD In Hematopoietic Cell Transplantation Recipients
2010
-
ALDHbr Hematopoietic Progenitors Promote Short-Term Engraftment In Experimental Models For Cord Blood Transplantation
2010
-
Aldehyde Dehydrogenase Cell Dosing Predicts The Dominating Cord In Double Cord Blood Transplantation
2010
-
Blockade Of Two Independent Innate Immunity Pathways Synergistically Prevent Lethal Graft-Versus-Host Disease
2010
-
Comparable Long-Term Leukemia-Free Survival After Matched Sibling And Unrelated Donor Transplantation For Children With Acute Lymphoblastic Leukemia In Second Complete Remission
2010
-
Correction Of Immune Defect, Excellent Survival, And Long-Term Donor Chimerism In Children With Chronic Granulomatous Disease After Myeloablative Transplantation Across Donor And Graft Sources
2010
-
Creation Of A Segment-Based Aldehyde Dehydrogenase Assay As A Biomarker For Umbilical Cord Blood Potency
2010
-
Myeloablative (MAC) Autologous Stem Cell Transplantation (AutoSCT) Followed By Reduced Intensity (RIC) Allogeneic Stem Cell Transplantation (AlloSCT) In Children, Adolescents And Young Adults (CAYA) With Poor Risk Hodgkin's Lymphoma (HL): Induction Of Long Term GVHL Effect
2010
-
Outcomes Of Matched Related Donor Hematopoietic Stem Cell Transplantation In Pediatric Patients With Myelodysplastic Syndrome
2010
-
Outcomes Of Transplantation Using A Various Cell Source In Children With Hurlers Syndrome After Myelo-Ablative Conditioning. An Eurocord-EBMT-CIBMTR Collaborative Study
2010
-
Polyoma Virus Is The Principal Cause Of Cystitis Following Alemtuzumab-Based Allogeneic Stem Cell Transplantation
2010
-
Quality Of Umbilical Cord Blood Units Stored For Autologous Use And Infused Intravenously In Children With Acquired Neurological Conditions
2010
-
Rising Numbers Of Recent Thymic Emigrants (RTE) Within The First Year After Unrelated Cord Blood Transplant (UCBT) Predict Overall Survival For Children: A Multivariate Analysis Following Myeloablative Conditioning And A Single Unit Graft
2010
-
Treatment Of Steroid-Refractory Acute GVHD With Mesenchymal Stem Cells Improves Outcomes In Pediatric Patients; Results Of The Pediatric Subset In A Phase III Randomized, Placebo-Controlled Study
2010
-
Complete Long-Term Hematopoietic Engraftment by Lineage-Depleted ALDH CD34+ UCB Cells
2009
-
Conditioning with Clofarabine and Busulfan X 4 (CloBu4) For Non-Remission Hematologic Malignancies Including Aml Is Well Tolerated, Facilitates Secure Engraftment, And Exhibits Significant Anti-Tumor Activity
2009
-
Human Memory T CELL S Elicit Decreased Cytotoxicity Against Allogeneic Targets
2009
-
Outcomes of Unrelated Umbilical Cord Blood Transplantation In Pediatric Patients With Primary and Secondary Myelodysplastic Syndromes
2009
-
Pericardial Effusion Following Unrelated Umbilical Cord Blood Transplantation: Analysis in a Cohort Of 423 Pediatric Patients Transplanted at a Single Center
2009
-
Prevention Of Acute GvHD During Haplo-BMT: Evaluating The Efficacy Of T-Cell Costimulation Blockade Using A Novel Rhesus Macaque Transplant Model
2009
-
Unrelated Umbilical Cord Blood Transplantation From A Single 4/6 Matched Unit is an Effective Therapy for Children With Malignant and Non-Malignant Diagnoses: Good Survival, Low Graft Failure and Graft-vs-Host Disease in a Single Center Analysis of 314 Patients
2009
-
105: Augmentation of Standard Umbilical Cord Blood Transplantation with ALDHbr Cells: Results of a Phase I Study in Pediatric Patients
2008
-
107: Post Thaw Colony Forming Units (CFU) is a Strong Independent Predictor of Engraftment after Unrelated Donor Umbilical Cord Blood Transplantation (UCBT)
2008
-
208: The Use, Safety, and Efficacy of Daclizumab for Steroid Refractory Graft-Versus-Host-Disease (GVHD) after Unrelated Cord Blood Transplantation (UCBT)
2008
-
224: Outcomes of Unrelated Umbilical Cord Blood Transplantation in Pediatric Patients with Myelodysplastic Syndrome
2008
-
23: A Novel Method to Reduce Rates of Extensive Chronic GvHD (cGvHD) without Increased Relapse for Cord Blood Transplant
2008
-
241: Successful Combined Unrelated Umbilical Cord Blood Haploidentical Transplant in Non Malignant Disease
2008
-
342: Rapamycin Prevents GVHD in Mouse Model through Novel Mechanism: Increase in Regulatory T cells
2008
-
366: Allospecific Effector Memory T cells have Decreased Ability to Induce Acute GVHD
2008
-
439: Pass it on
2008
-
63: Outcomes of Unrelated Umbilical Cord Blood Transplantation in 159 Young Patients with Peroxisomal and Lysosomal Storage Disorders at a Single Center
2008
-
78: Chronic Hepatitis C, Cirrhosis, and End Stage Liver Disease Among 30-Year Survivors of Bone Marrow Transplant
2008
-
RISK FACTOR ANALYSIS OF OUTCOMES AFTER UNRELATED CORD BLOOD TRANSPLANTATION FOR CHILDREN WITH HURLERS SYNDROME. AN EUROCORD-DUKE UNIVERSITY COLLABORATIVE STUDY
2008
-
UNRELATED DONOR UMBILICAL CORD BLOOD TRANSPLANT FOR HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH)
2008
-
109: A pilot trial of unrelated donor umbilical cord blood transplanation (UCBT) augmented with cytokine-primed aldehyde dehydrogenase-bright (ALDHbr) cells
2007
-
172: Post transplant autoimmune hemolytic anemia and other cytopenias are increased in young babies undergoing unrelated donor umbilical cord blood transplantation
2007
-
173: Outcomes of matched related donor bone marrow transplantation in pediatric patients with myelodysplastic syndrome
2007
-
180: Chronic graft-versus host disease (GVHD) in children with mucopolysacharidoses (MPS) two years after unrelated donor umbilical cord blood transplantation (UCBT)
2007
-
189: γδ T cells as immunotherapy for glioblastoma multiforme
2007
-
23: Early hematopoietic cells, including megakaryocyte progenitors, are recovered in ALDH bright cell populations isolated by cell sorting from previously frozen umbilical cord blood
2007
-
345: Radioprotection by growth hormone
2007
-
372: Educating the pediatric blood and marrow transplant patients and families with diagnoses of genetic versus malignant diagnoses
2007
-
376: Treatment of acute graft vs. host disease after unrelated donor umbilical cord blood transplantation in pediatric patients
2007
-
377: Outcomes of pediatric patients transplanted a second time after experiencing graft failure with unrelated donor umbilical cord blood transplantation
2007
-
379: Fly me to the moon
2007
-
396: Nursing care of the child receiving inhaled ribavirin for the treatment of RSV in the peritransplant period
2007
-
413: The Duke pediatric blood and marrow transplant nursing graduate integration program
2007
-
414: Engraftment syndrome
2007
-
423: Prophylaxis of pneumocystis carinii pneumonia (PCP) with inhaled pentamidine in pediatric patients undergoing hematopoietic stem cell transplantation
2007
-
Outcomes of unrelated umbilical cord blood transplantation in pediatric patients with myelodysplastic syndrome
2007
-
Activation and enhancement of ex vivo (EvE) expanded cryopreserved Cord Blood (CB) Natural Killer (NK) cells, cytolytic potential, and NK receptor (NKR) expression: Potential role for CB NK in Adoptive Cellular Immunotherapy (ACI)
2006
-
Busulfan/melphalan is an effective and well tolerated conditioning regimen for pediatric AML and MDS patients receiving a matched sibling BMT
2006
-
Cellcept/cyclosporine as prophylaxis against graft- versus-host disease in pediatric patients undergoing allogeneic stem cell transplantation
2006
-
Compassion fatigue: Care for the caring
2006
-
Expansion of umbilical cord blood derived oligodendrocytes
2006
-
Failure of memory T cells to induce GVHD is a result of an abortive alloresponse
2006
-
Graves’ disease following unrelated umbilical cord blood transplantation in pediatric patients
2006
-
Impact of donor KIR genotype and recipient HLA ligand incompatibility on relapse related mortality and acute graft versus host disease in high-risk patients undergoing haploidentical non-myeloablative peripheral blood stem cell transplants: Differences between lymphoid and myeloid malignancies
2006
-
Implementation of discharge videos for pediatric patients undergoing blood and marrow transplantation: Bridging the gap between inpatient and outpatient care
2006
-
Neonatal umbilical cord blood transplantation favorably alters the neurodevelopmental outcome and survival of babies with infantile Krabbe disease
2006
-
Neurobehavioral outcome in children with MPS III (Sanfilippo Syndrome) after unrelated donor umbilical cord blood transplantation (UCBT)
2006
-
Non-myeloablative allogeneic transplantation with alemtuzumab, fludarabine and cyclophosphamide using 3-6/6 HLA matched donors
2006
-
Nursing care of the granulocyte donor for pediatric stem cell transplant patients
2006
-
Patient controlled analgesia by proxy
2006
-
Rapid in vivo acquisition of effector Tc1 phenotype prior to myeloid engraftment predicts opportunistic infections in unrelated cord blood transplant recipients
2006
-
Recipient outcomes data collection and reporting for cord blood bank follow-up and quality assurance purposes: The National Marrow Donor Program® experience
2006
-
Single center experience of unrelated umbilical cord blood transplantation (UCBDT) for acute myeloid leukemia (AML) in 97 pediatric patients: Impact of disease status and cytoreductive regimen
2006
-
Umbilical cord blood transplantation in pediatric patients: Results of the prospective, multi-institutional Cord Blood Transplantation Study (COBLT)
2006
-
Veno Occulsive disease: A potentially life threatening complication of hematopoietic stem cell transplantation
2006
-
Dendritic cell and T-cell subsets correlate with the development and site of acute GVHD following unrelated cord blood transplantation in children: A multivariate analysis
2005
-
EBV-associated leiomyomas following haploidentical transplantation for X-linked severe combined immunodeficiency disease
2005
-
Efficient enrichment and flow sorting of aldehyde dehydrogenase bright hematopoietic progenitor cells from thawed, banked umbilical cord blood
2005
-
Establishment of a National Cord Blood Banking Network through the National Marrow Donor Program
2005
-
Infection in the pediatric patient after bone marrow or stem cell transplantation: Nursing considerations
2005
-
Management of cytomegalovirus in the pediatric bone marrow/stem cell transplantation population
2005
-
Mature T cells alone separate GVL from GVHD: The need for better controls
2005
-
Outcomes of unrelated umbilical cord blood transplantation in pediatric patients with myelodysplastic syndrome
2005
-
Results of the Cord Blood Transplantation Study (COBLT): Clinical outcomes of 193 unrelated donor umbilical cord blood transplantation in pediatric patients with malignant conditions
2005
-
Results of the cord blood transplantation study (COBLT): Clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with inborn errors of metabolism
2005
-
Single center experience with collection and administration of G-CSF–mobilized, irradiated granulocyte transfusions from directed donors to support patients at high risk for infections undergoing unrelated donor blood and marrow transplantation
2005
-
Treatment of pediatric patients with Sanfilippo syndrome (MPS IIIA and IIIB) with unrelated umbilical cord blood transplantation
2005
-
Treatment options and nursing care for the pediatric aplastic anemia patient requriring bone marrow or stem cell transplantation
2005
-
Cord blood transplantation in genetic disorders
2004
-
A novel approach for ex-vivo expansion (EvE) of NK CD3−/CD16+/56+bright/dim subsets expressing increased inhibitory receptors from cryopreserved/thawed/expanded/recryopreserved/rethawed (CTECT) and cryopreserved/thawed/recryopreserved/rethawed/expanded (CTCTE) umbilical cord blood (UCB) using anti-CD3, IL-2, IL-7 and IL-12 (AB/CY)
2004
-
Continuous platelet drip: a unique approach in the treatment of severe/refractory thrombocytopenia in the pediatric stem cell transplant population
2004
-
Ex vivo expansion of immature and mature T cells derived from umbilical cord blood (UCB)
2004
-
Isolation of oligodendrocyte precursors from umbilical cord blood
2004
-
Non-GVHD-inducing CD62L− memory T cells promote new T cell regeneration from hematopoietic stem cells
2004
-
Results of the cord blood transplantation study (COBLT) unrelated donor banking program
2004
-
Second hematopoietic stem cell transplant using unrelated donor umbilical cord blood cures 50% of pediatric patients with leukemia relapsing after prior allogeneic transplant from a matched related sibling
2004
-
The impact of immune reconstitution in the early post grafting period on the development of opportunistic infections after unrelated cord blood transplantation. A multivariate analysis of host, graft, and day +50 immune profile
2004
-
Transplantation of boys with X-linked adrenoleukodystrophy with unrelated-donor, partially HLA-mismatched banked umbilical cord blood
2004
-
Umbilical cord blood cells engraft and differentiate in cardiac tissues after human tranplantation
2004
-
Unrelated umbilical cord blood transplantation for familial erythrophagocytic lymphohistiocytosis
2004